| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | NEUTRAL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.50▼ | 1.49▼ | 1.49▼ | 1.61▼ | 1.59▼ |
| MA10 | 1.50▼ | 1.49▼ | 1.53▼ | 1.65▼ | 1.37▲ |
| MA20 | 1.50▼ | 1.54▼ | 1.59▼ | 1.56▼ | 0.89▲ |
| MA50 | 1.50▼ | 1.62▼ | 1.65▼ | 1.27▲ | 0.75▲ |
| MA100 | 1.55▼ | 1.65▼ | 1.61▼ | 0.84▲ | 1.56▼ |
| MA200 | 1.62▼ | 1.60▼ | 1.46▲ | 0.67▲ | 2.15▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▼ | -0.001▼ | -0.012▼ | -0.029▼ | 0.105▲ |
| RSI | 37.972▼ | 33.903▼ | 34.453▼ | 50.088▲ | 65.397▲ |
| STOCH | 66.667 | 26.396 | 12.271▼ | 32.949 | 81.506▲ |
| WILL %R | -100.000▼ | -89.655▼ | -94.000▼ | -68.831 | -32.121 |
| CCI | -234.595▼ | -53.437 | -88.982 | -62.985 | 83.012 |
| ▼ BREAK | $OVID Price Breaks 10 Days Low | Set Alert |
|
Thursday, October 09, 2025 09:32 AM
Ovid Therapeutics (NASDAQ:OVID) added ~13% on Thursday after Wedbush revised its rating to Outperform from not rated, citing the neuro drug developer’s lead candidate OV329 targeted at rare and ...
|
|
Friday, October 03, 2025 12:25 PM
OVID reported positive phase 1 results for OV329, a next-generation GABA-AT inhibitor targeting drug-resistant focal onset seizures. Read why OVID is a Hold.
|
|
Friday, October 03, 2025 06:12 AM
Shares of Ovid Therapeutics Inc. (OVID) jumped 18% in the pre-market session on Friday after the company announced positive results from an early-stage trial of its OV329, as well as the pricing of a ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 17/10/25 | 1.55 | 1.61 | 1.46 | 1.48 | 2,061,924 |
| 16/10/25 | 1.64 | 1.72 | 1.56 | 1.57 | 1,951,913 |
| 15/10/25 | 1.76 | 1.76 | 1.63 | 1.65 | 1,667,612 |
| 14/10/25 | 1.57 | 1.785 | 1.5332 | 1.75 | 2,512,150 |
| 13/10/25 | 1.72 | 1.72 | 1.57 | 1.58 | 2,001,575 |
| 10/10/25 | 1.82 | 1.84 | 1.65 | 1.67 | 3,995,310 |
| 09/10/25 | 1.72 | 1.86 | 1.67 | 1.74 | 5,095,048 |
| 08/10/25 | 1.67 | 1.67 | 1.57 | 1.58 | 2,251,838 |
| 07/10/25 | 1.77 | 1.77 | 1.62 | 1.67 | 3,989,437 |
| 06/10/25 | 1.86 | 1.89 | 1.71 | 1.79 | 4,884,783 |
|
|
||||
|
|
||||
|
|